Literature DB >> 12898046

[Central anticholinergic syndrome and apnea after general anaesthesia. A rare manifestation of the central anticholinergic syndrome].

I Senne1, C Zourelidis, D Irnich, M Kurz, T Hummel, B Zwissler.   

Abstract

The central anticholinergic syndrome (CAS) is a rarely observed condition after general anaesthesia. There are no definitive criteria to set the diagnosis of CAS. The syndrome may manifest in clinical neurological signs, such as hyperactive states or a depressed CNS state. The diagnosis usually depends on a process of exclusion of other conditions and is confirmed after rapid recovery following administration of physostigmine. We report on a 34-year-old patient who suddenly lost consciousness and developed respiratory arrest 1 h after general anesthesia and normal postoperative recovery. CAS was considered, although apnea has not been reported as a clinical symptom of this disease up to now and no peripheral signs of CAS were observed. After the administration of 1 mg physostigmine the symptoms resolved immediately and the patient started sufficient spontaneous breathing. However, corresponding to the plasma elimination half-life of the drug, further comatose episodes with apnea occurred. Therefore, the patient was admitted to the ICU and an infusion of physostigmin at a rate of up to 5 mg/h was started. Due to this therapy the patient's state became stable and 15 h after the first manifestation of CAS the infusion of physostigmin was discontinued. The following postoperative course was uneventful. In case of reduced vigilance with apnea after general anaesthesia, central anticholinergic syndrome should be considered. For diagnostic and therapeutic purposes the administration of physostigmine should be attempted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898046     DOI: 10.1007/s00101-003-0486-y

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  7 in total

1.  Undiagnosed central anticholinergic syndrome may lead to dangerous complications.

Authors:  K Katsanoulas; A Papaioannou; O Fraidakis; D Michaloudis
Journal:  Eur J Anaesthesiol       Date:  1999-11       Impact factor: 4.330

2.  [Central anticholinergic syndrome in intensive care patients].

Authors:  S Brede; R Dennhardt
Journal:  Klin Wochenschr       Date:  1991

3.  Distinct central anticholinergic syndrome following general anaesthesia.

Authors:  J Link; G Papadopoulos; D Dopjans; I Guggenmoos-Holzmann; K Eyrich
Journal:  Eur J Anaesthesiol       Date:  1997-01       Impact factor: 4.330

Review 4.  Central anticholinergic syndrome on therapeutic doses of cyproheptadine.

Authors:  N M Watemberg; K S Roth; F K Alehan; C E Epstein
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

Review 5.  Behavioral and electroencephalographic effects of atropine and related compounds.

Authors:  V G Longo
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

6.  Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.

Authors:  R P Granacher; R J Baldessarini
Journal:  Arch Gen Psychiatry       Date:  1975-03

Review 7.  Central anticholinergic syndrome (CAS) in anesthesia and intensive care.

Authors:  H J Schneck; J Rupreht
Journal:  Acta Anaesthesiol Belg       Date:  1989
  7 in total
  2 in total

1.  [33-year-old female with postanesthesia unconsciousness, tachycardia and excessively warm skin : Preparation for the medical specialist examination: part 47].

Authors:  R Chackupurakal; F Wappler; S G Sakka
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

2.  [Intracranial haemorrhage. A reason for delayed awakening after general anaesthesia].

Authors:  K Morgenthaler; B Larsen; U Grundmann; M Silomon
Journal:  Anaesthesist       Date:  2005-05       Impact factor: 1.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.